Previous studies have reported altered IGFBP-1 levels in patients with type 2 diabetes, with several studies describing increased concentrations, while others have demonstrated decreased levels depending on patient characteristics [11]. This evidence concerns the gene IGFBP1 and type 2 diabetes mellitus.